Skip to main content
SpringerLink
Log in

Can we learn more about the etiology of cardiovascular disease?

  • Commentary
  • Published:
European Journal of Epidemiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Yusuf S, Hawken S, Ôunpuu S, et␣al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study). Lancet 2004; 364: 937–52

    Article  PubMed  Google Scholar 

  2. Dzau VJ, Antman EM, Black HR, et␣al. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes. Part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease). Circulation 2006; 114: 2850–870

    Article  PubMed  Google Scholar 

  3. Tedgui A, Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 2006; 86: 515–81

    Article  CAS  PubMed  Google Scholar 

  4. Godsland IF, Bruce R, Jeffs JAR, Leyva F, Walton C, Stevenson JC. Inflammation markers and erythrocyte sedimentation rate but not metabolic syndrome factor score predict coronary heart disease in high socioeconomic class males: the HDDRISC study. Int J Cardiol 2004; 97: 543–50

    Article  PubMed  Google Scholar 

  5. Lorenzo C, Williams K, Hunt KJ, Haffner SM. The National Cholesterol Education Program-Adult Treatment Panel III, International Diabetes Federation, and World Health Organization definitions of the metabolic syndrome as predictors of incident cardiovascular disease and diabetes. Diabetes Care 2007; 30: 8–3

    Article  PubMed  Google Scholar 

  6. Kuller LH, Grandits G, Cohen JD, Neaton JD, Prineas R, for the Multiple Risk Factor Intervention Trial Research Group. Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome. Atherosclerosis, In Press, Available Online 2 October 2006

  7. Key TJ, Appleby PN, Davey GK, Allen NE, Spencer EA, Travis RC. Mortality in British vegetarians: review and preliminary results from EPIC-Oxford. Am J Clin Nutr 2003; 78: 533S–38S

    CAS  PubMed  Google Scholar 

  8. Ferrario M, Chiodini P, Chambless LE, et␣al. for the CUORE Project Research Group. Prediction of coronary events in a low incidence population. Assessing accuracy of the CUORE Cohort Study prediction equation. Int J Epidemiol 2005; 34: 413–21

    Google Scholar 

  9. Stamloer J, Elliott P, Dennis B, et␣al. for the INTERMAP Research Group. INTERMAP: background, aims, design, methods, and descriptive statistics (nondietary). J Hum Hypertens 2003; 17: 591–08

    Google Scholar 

  10. MRFIT Research Group. Dietary and nutritional methods and findings: the Multiple Risk Factor Intervention Trial (MRFIT). Am J Clin Nutr 1997; 65(suppl.):183S–02S

    Google Scholar 

  11. Keys A (ed.) Coronary heart disease in seven countries. Circulation 1970; 41–2(suppl. I):I-1-I-211

  12. Mackenback JP. The Mediterranean diet story illustrates that “why” questions are as important as “how” questions in disease explanation. J Clin Epidemiol 2007; 60: 105–09

    Article  Google Scholar 

  13. Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 2006; 354: 1264–272

    Article  CAS  PubMed  Google Scholar 

  14. Naukkarinen J, Ehnholm C, Peltonen L. Genetics of familial hyperlipidemia. Curr Opin Lipidol 2006; 17: 285–90

    Article  CAS  PubMed  Google Scholar 

  15. Visvikis-Siest S, Marteau J-B. Genetic variants predisposing to cardiovascular disease. Curr Opin Lipidol 2006; 17: 139–51

    Article  CAS  PubMed  Google Scholar 

  16. Navab M, Ananthramaiah GM, Reddy ST, et␣al. The double jeopardy of HDL. Ann Med 2005; 37: 173–78

    Article  CAS  PubMed  Google Scholar 

  17. Brouilette SW, Moore JS, McMahon AD, et␣al. for the West of Scotland Coronary Prevention Study Group. Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study. Lancet 2007; 369: 107–14

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Epidemiology, University of Pittsburgh, 130 North Bellefield Avenue, Room 550, Pittsburgh, PA, 15213, USA

    Lewis H. Kuller

Authors
  1. Lewis H. Kuller
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lewis H. Kuller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kuller, L.H. Can we learn more about the etiology of cardiovascular disease?. Eur J Epidemiol 22, 79–81 (2007). https://doi.org/10.1007/s10654-007-9116-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10654-007-9116-3

Keywords

Search

Navigation